Rchr
J-GLOBAL ID：202001010284564822
Update date: Jul. 03, 2024
Okazaki Keito
オカザキ ケイト | Okazaki Keito
Affiliation and department：
Research theme for competitive and other funds (3)：
- 2024 - 2027 難治性がんにおけるRegnase-1によるRNA分解調節機構の検証
- 2022 - 2024 Regnase-1による転写後制御が創出するがん悪性化機構の解明
- 2020 - 2022 Research for unveiled molecular mechanism underlying cancer malignancy
Papers (10)：
-
Makiko Hayashi, Keito Okazaki, Thales Papgiannakopoulos, Hozumi Motohashi. The Complex Roles of Redox and Antioxidant Biology in Cancer. Cold Spring Harbor Perspectives in Medicine. 2024. a041546-a041546
-
Kazuki Hayasaka, Shinya Ohkouchi, Ryoko Saito-Koyama, Yamato Suzuki, Keito Okazaki, Hiroki Sekine, Tatsuaki Watanabe, Hozumi Motohashi, Yoshinori Okada. Aging Exacerbates Murine Lung Ischemia-Reperfusion Injury by Excessive Inflammation and Impaired Tissue Repair Response. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2023
-
Shohei Murakami, Yusuke Kusano, Keito Okazaki, Takaaki Akaike, Hozumi Motohashi. NRF2 signalling in cytoprotection and metabolism. British journal of pharmacology. 2023
-
Keito Okazaki, Hayato Anzawa, Fumiki Katsuoka, Kengo Kinoshita, Hiroki Sekine, Hozumi Motohashi. CEBPB is required for NRF2-mediated drug resistance in NRF2-activated non-small cell lung cancer cells. The Journal of Biochemistry. 2022. 171. 5. 567-578
-
Keito Okazaki, Hayato Anzawa, Zun Liu, Nao Ota, Hiroshi Kitamura, Yoshiaki Onodera, Md Morshedul Alam, Daisuke Matsumaru, Takuma Suzuki, Fumiki Katsuoka, et al. Publisher Correction: Enhancer remodeling promotes tumor-initiating activity in NRF2-activated non-small cell lung cancers. Nature communications. 2021. 12. 1. 506-506
ｍore...
Books (1)：
-
ゲノム医療時代のがん : 分子標的薬と診断薬研究
羊土社 2020 ISBN:9784758103893
Lectures and oral presentations (4)：
-
NRF2活性化非小細胞肺がんにおけるRNA分解酵素Rengase-1の役割
(第96回日本生化学会大会 2023)
-
NRF2活性化がんにおけるRNA分解酵素Regnase-1の役割.
(第81回日本癌学会学術総会 2022)
-
NRF2活性化状態におけるCEBPB依存的な転写制御とその意義
(第80回日本癌学会学術総会 2021)
-
Enhancer Remodeling at the NOTCH3 Locus Licenses NRF2 for the Promotion of a Stem-like Phenotype in Lung Cancers.
(Environmental Response V/17th JBS Biofrontier Symposium 2019)
Professional career (1)：
Awards (5)：
- 2022 - 東北大学艮陵医学振興会 勾坂記念賞
- 2021 - 東北大学加齢医学研究所 研究奨励賞
- 2021 - 日本生化学会 東北支部 優秀論文賞
- 2020 - 日本癌学 第一回日本癌学会若手の会 最優秀発表賞
- 2014 - 日本生化学会 若手優秀発表賞
Return to Previous Page
